What is PATH?
Headquartered in Seattle, Washington, PATH operates as a nonprofit organization focused on the intersection of innovation and health equity. By providing essential resources to innovators and health practitioners, the company bridges the gap between complex medical challenges and scalable, community-based solutions. Its market position is defined by a long-term commitment to sustainable development, leveraging deep expertise in health technology and public policy to address unmet needs across diverse global populations.
The organization's growth trajectory, marked by successive rounds of financing from 2010 through 2017, highlights its transition from a foundational research entity to a robust, enterprise-level operation. By maintaining a focus on health equity, PATH continues to influence the global health landscape, ensuring that its strategic initiatives remain aligned with the evolving requirements of the communities it serves.
How much funding has PATH raised?
PATH has raised a total of $100.2M across 6 funding rounds:
Angel/Seed
$2.5M
Series A
$10.8M
Series B
$30M
Series C
$24.9M
Unspecified
$7M
Other Financing Round
$25M
Angel/Seed (2010): $2.5M with participation from Index Ventures, Founders Fund, SV Angel, and First Round Capital
Series A (2011): $10.8M led by Kleiner Perkins Caufield & Byers, Digital Garage, First Round Capital, and Index Ventures
Series B (2012): $30M supported by Index Ventures, Allen & Company, Greylock Partners, Kleiner Perkins Caufield & Byers, Redpoint Ventures, and Shasta Ventures
Series C (2013): $24.9M featuring Insight Venture Partners, Greylock Partners, Kleiner Perkins Caufield & Byers, Bakrie & Brothers, First Round Capital, Redpoint Venture Partners, and Index Ventures
Unspecified (2013): $7M, investors not publicly disclosed
Other Financing Round (2017): $25M with participation from Clarus Ventures
Key Investors in PATH
Index Ventures
Index Ventures is a venture firm investing in the next generation of entrepreneurs from seed to IPO, partnering with founders who challenge the status quo to build enduring companies.
Kleiner Perkins Caufield & Byers
Kleiner Perkins is a Menlo Park-based venture capital firm that invests in early and growth-stage technology and life-science companies, providing capital and operational support.
First Round Capital
Baseline Ventures is a venture capital firm that invests in innovative startups across various sectors, focusing on supporting entrepreneurs to achieve significant market results.
What's next for PATH?
Looking ahead, the strategic deployment of $25M is expected to bolster PATH's core mission of fostering health equity through technological and operational innovation. As the organization continues to scale, the focus will likely remain on deepening its impact in underserved regions and expanding its network of global health partners. The sustained support from institutional investors underscores a shared confidence in the organization's ability to navigate the complexities of the global health sector.
Future initiatives will likely prioritize the integration of advanced health technologies and the strengthening of local health systems. By leveraging its established reputation and the capital secured through its recent strategic investment, PATH is well-positioned to address emerging health crises and drive long-term, sustainable improvements in global health outcomes.
